Logo image of ECG

EVERUS CONSTRUCTION GROUP (ECG) Stock Fundamental Analysis

NYSE:ECG - New York Stock Exchange, Inc. - US3004261034 - Common Stock - Currency: USD

58.78  -0.67 (-1.13%)

After market: 58.78 0 (0%)

Fundamental Rating

4

ECG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 51 industry peers in the Construction & Engineering industry. ECG has only an average score on both its financial health and profitability. ECG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

ECG had positive earnings in the past year.
ECG Yearly Net Income VS EBIT VS OCF VS FCFECG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

ECG has a better Return On Assets (11.20%) than 86.27% of its industry peers.
ECG has a better Return On Equity (33.00%) than 84.31% of its industry peers.
ECG has a better Return On Invested Capital (18.34%) than 88.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ECG is above the industry average of 16.97%.
Industry RankSector Rank
ROA 11.2%
ROE 33%
ROIC 18.34%
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ECG Yearly ROA, ROE, ROICECG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30

1.3 Margins

ECG has a Profit Margin of 4.98%. This is in the better half of the industry: ECG outperforms 70.59% of its industry peers.
ECG's Profit Margin has declined in the last couple of years.
The Operating Margin of ECG (6.62%) is better than 60.78% of its industry peers.
ECG's Operating Margin has declined in the last couple of years.
ECG has a Gross Margin of 11.71%. This is in the lower half of the industry: ECG underperforms 64.71% of its industry peers.
ECG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.62%
PM (TTM) 4.98%
GM 11.71%
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
ECG Yearly Profit, Operating, Gross MarginsECG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2 4 6 8 10

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ECG is creating value.
Compared to 1 year ago, ECG has about the same amount of shares outstanding.
ECG has a worse debt/assets ratio than last year.
ECG Yearly Shares OutstandingECG Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
ECG Yearly Total Debt VS Total AssetsECG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ECG has an Altman-Z score of 5.46. This indicates that ECG is financially healthy and has little risk of bankruptcy at the moment.
ECG has a better Altman-Z score (5.46) than 80.39% of its industry peers.
ECG has a Debt/Equity ratio of 0.60. This is a neutral value indicating ECG is somewhat dependend on debt financing.
ECG has a Debt to Equity ratio of 0.60. This is comparable to the rest of the industry: ECG outperforms 52.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z 5.46
ROIC/WACC1.78
WACC10.3%
ECG Yearly LT Debt VS Equity VS FCFECG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

ECG has a Current Ratio of 1.78. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
ECG has a better Current ratio (1.78) than 86.27% of its industry peers.
ECG has a Quick Ratio of 1.69. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ECG (1.69) is better than 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.69
ECG Yearly Current Assets VS Current LiabilitesECG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.30% over the past year.
Measured over the past years, ECG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.37% on average per year.
ECG shows a decrease in Revenue. In the last year, the revenue decreased by -0.16%.
ECG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.57% yearly.
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%29.68%
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%32.11%

3.2 Future

ECG is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.74% yearly.
The Revenue is expected to grow by 8.59% on average over the next years. This is quite good.
EPS Next Y-11.04%
EPS Next 2Y-0.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.64%
Revenue Next 2Y8.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ECG Yearly Revenue VS EstimatesECG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 1B 2B 3B
ECG Yearly EPS VS EstimatesECG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.79, ECG is valued on the expensive side.
ECG's Price/Earnings ratio is rather cheap when compared to the industry. ECG is cheaper than 82.35% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.17, ECG is valued a bit cheaper.
ECG is valuated rather expensively with a Price/Forward Earnings ratio of 21.15.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ECG is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ECG is around the same levels.
Industry RankSector Rank
PE 19.79
Fwd PE 21.15
ECG Price Earnings VS Forward Price EarningsECG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ECG is valued a bit cheaper than 64.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.15
ECG Per share dataECG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.74%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ECG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVERUS CONSTRUCTION GROUP

NYSE:ECG (5/28/2025, 8:04:01 PM)

After market: 58.78 0 (0%)

58.78

-0.67 (-1.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-05 2025-08-05
Inst Owners71.96%
Inst Owner Change5.67%
Ins Owners0.02%
Ins Owner Change24.43%
Market Cap3.00B
Analysts80
Price Target58.82 (0.07%)
Short Float %4%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.93%
Min EPS beat(2)-3.53%
Max EPS beat(2)65.4%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)16.22%
Min Revenue beat(2)11.43%
Max Revenue beat(2)21.01%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.49%
PT rev (3m)-15.61%
EPS NQ rev (1m)1.93%
EPS NQ rev (3m)1.93%
EPS NY rev (1m)0.13%
EPS NY rev (3m)0.13%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-0.92%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE 19.79
Fwd PE 21.15
P/S 0.98
P/FCF N/A
P/OCF N/A
P/B 6.51
P/tB 9.46
EV/EBITDA 14.15
EPS(TTM)2.97
EY5.05%
EPS(NY)2.78
Fwd EY4.73%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS59.82
BVpS9.02
TBVpS6.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.2%
ROE 33%
ROCE 24.94%
ROIC 18.34%
ROICexc 20.19%
ROICexgc 25.07%
OM 6.62%
PM (TTM) 4.98%
GM 11.71%
FCFM N/A
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ROICexc(3y)19.99%
ROICexc(5y)N/A
ROICexgc(3y)25.54%
ROICexgc(5y)N/A
ROCE(3y)26.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA 1.22
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.69
Altman-Z 5.46
F-ScoreN/A
WACC10.3%
ROIC/WACC1.78
Cap/Depr(3y)170.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%29.68%
EPS Next Y-11.04%
EPS Next 2Y-0.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%32.11%
Revenue Next Year10.64%
Revenue Next 2Y8.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.33%
EBIT growth 3Y9.22%
EBIT growth 5YN/A
EBIT Next Year18.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.21%
FCF growth 3Y25.55%
FCF growth 5YN/A
OCF growth 1Y-4.65%
OCF growth 3Y24.12%
OCF growth 5YN/A